References of "Abraham, I"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detail"Real-life" effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST study.
Brusselle, G.; Michils, A.; Louis, Renaud ULg et al

in Respiratory medicine (2009), 103(11), 1633-42

OBJECTIVE: To evaluate the 16- and 52-week effectiveness of add-on omalizumab treatment under real-life heterogeneity in patients, settings, and physicians in an open-label, multicenter, pharmaco ... [more ▼]

OBJECTIVE: To evaluate the 16- and 52-week effectiveness of add-on omalizumab treatment under real-life heterogeneity in patients, settings, and physicians in an open-label, multicenter, pharmaco-epidemiologic study of patients with severe persistent allergic asthma in Belgium. METHODS: Effectiveness outcomes included improvement in 2005 global initiative for asthma (GINA) classification, physician-rated global evaluation of treatment effectiveness (GETE), quality of life (Juniper asthma-related quality of life (AQLQ) and European quality of life questionnaire 5 dimensions (EQ-5D)), and severe asthma exacerbations. Patients studied included both intent-to-treat and per-protocol populations. RESULTS: The sample (n=158) had a mean age of 48.17+/-17.18 years, and a slight majority were female (53.8%). Despite being treated with high-dose inhaled corticosteroids and long-acting beta2-agonists, all patients experienced frequent symptoms and had exacerbations in the past year. At 16 weeks, >82% had good/excellent GETE (P values <0.001), >82% had an improvement in total AQLQ scores of > or =0.5 points (P<0.001), and >91% were severe exacerbation-free (P<0.001). At 52 weeks, >72% had a good/excellent GETE rating (P<0.001), >84% had improvements in total AQLQ score of > or =0.5 points (P<0.001), >56% had minimally important improvements in EQ-5D utility scores (P=0.012), and >65% were severe exacerbation-free (P<0.001). Significant reductions in healthcare utilization compared to the one year prior to treatment were noted. CONCLUSION: The PERSIST study shows better physician-rated effectiveness, greater improvements in quality of life, greater reductions in exacerbation rates, and greater reductions in healthcare utilization than previously reported in efficacy studies. Under real-life conditions, omalizumab is effective as add-on therapy in the treatment of patients with persistent severe allergic asthma. [less ▲]

Detailed reference viewed: 47 (5 ULg)
Full Text
Peer Reviewed
See detailImplementation of discharge management for geriatric patients at risk of readmission or institutionalization
Steeman, E.; Moons, P.; Milisen, K. et al

in International Journal for Quality in Health Care (2006), 18(5), 352-358

Objective. To evaluate whether implementation of discharge management by trained social workers or nurses reduces hospital readmissions and institutionalizations of geriatric patients in a real-world ... [more ▼]

Objective. To evaluate whether implementation of discharge management by trained social workers or nurses reduces hospital readmissions and institutionalizations of geriatric patients in a real-world setting. Design. Quasi-experimental design. Setting. Six general hospitals in Belgium. Participants. A representative sample of 824 patients, 355 of whom were assigned to the experimental group receiving comprehensive discharge management and 469 to the control group receiving usual care. Inclusion criteria were patients admitted to a geriatric, rehabilitation, or internal medicine ward, not residing in a nursing home, and showing risk of readmission or institutionalization on admission in the hospital. Intervention. In-hospital discharge planning according to a case management protocol allowing for adjustment to participating hospitals' case mix and patients' and families' specific needs. Main outcome measures. Hospital readmission within 15 and 90 days post discharge; institutionalization at discharge and within 15 and 90 days post discharge. Results. Discharge management resulted in fewer institutionalizations (n = 53; 14.9%) compared with usual care (n = 130; 23.7%) (adjusted odds ratio = 0.47; CI 95% = 0.31-0.70). Readmission rates between the intervention and usual care group were not significantly different. Conclusions. This implementation project showed that a discharge planning intervention can reduce institutionalization rates of elderly patients in real-life settings. [less ▲]

Detailed reference viewed: 37 (2 ULg)
See detailPilootproject : ontslagmanagement in Belgische ziekenhuizen. [Pilot study : discharge management in Belgian hospitals]. Final report, 2000
Abraham, I; Bollen, S; de Froidmont, C et al

Report (2000)

Detailed reference viewed: 11 (3 ULg)
See detailEtude pilote : Case management intégré dans les hôpitaux belges.
de Froidmont, C.; Dejace, Alain ULg; Englebert, L. et al

Report (1999)

Detailed reference viewed: 22 (4 ULg)
Peer Reviewed
See detailCase Management : a multidisciplinary approach to prevent institutionalization of high-risk elderly
Moons, P; Borgermans, L; Milisen, K et al

Conference (1998)

Detailed reference viewed: 3 (0 ULg)
See detailCase Management voor geriatrische patienten en hun families : Het klinisch model van belgische projecten
Borgermans, L.; Abraham, I.; Milisen, K. et al

in Tijdschrift voor de Geschiedenis der Geneeskunde, Natuurwetenschappen, Wiskunde en Techniek (1998), 54(6), 427-435

Detailed reference viewed: 19 (0 ULg)
Peer Reviewed
See detailCase Management pour des patients psychogériatriques à domicile
Dejace, Alain ULg; Gosset, Christiane ULg; Borgemans, L et al

Conference (1996)

Detailed reference viewed: 2 (0 ULg)
Peer Reviewed
See detailCase management voor psychogeriatrishe patiënten: theoritisch kader van een verpleegkundig demonstratieproject
Borgermans, L.; Milisen, K.; Dejace, Alain ULg et al

in Acta Hospitalia (1996), 4

Detailed reference viewed: 20 (0 ULg)
Peer Reviewed
See detailCase management voor psychogeriatrishe patiënten: de case manager
Borgermans, L.; Milisen, K.; Dejace, Alain ULg et al

in Acta Hospitalia (1996), 4

Detailed reference viewed: 7 (0 ULg)
Peer Reviewed
See detailCase management voor psychogeriatrishe patiënten: gezondheidstoestand van deze ouderen en de zorgbelasting van hun centrale verzorgers
Milisen, K.; Borgermans, L.; Dejace, Alain ULg et al

in Acta Hospitalia (1996), 4

Detailed reference viewed: 28 (0 ULg)